Home
|
Learning Center
|
中文版
Publications
站内成果搜索:
搜索
Paclitaxel-and platinum-based postoperative chemotherapy for primary fallopian tube carcinoma: A single institution experience
Paclitaxel delivery using carrier made from curcumin derivative: Synergism between carrier and the loaded drug for effective cancer treatment
Paclitaxel and etoposide co-loaded polymeric nanoparticles for the effective combination therapy against human osteosarcoma
Paclitaxel plus Doxorubicin Chemotherapy as Second-Line Therapy in Patients with Advanced Urothelial Carcinoma Pretreated with Platinum plus Gemcitabine Chemotherapy
Paclitaxel-induced hyposensitivity to nociceptive chemical stimulation in mice can be prevented by treatment with minocycline
Paclitaxel loaded PEGylated gleceryl monooleate based nanoparticulate carriers in chemotherapy
Paclitaxel-based regimens as first-line treatment in advanced gastric cancer
Paclitaxel-loaded lipid nanoparticles prepared by solvent injection or ultrasound emulsification
Paclitaxel-Loaded Expansile Nanoparticles Delay Local Recurrence in a Heterotopic Murine Non-Small Cell Lung Cancer Model
Paclitaxel therapy potentiates cold hyperalgesia in streptozotocin-induced diabetic rats through enhanced mitochondrial reactive oxygen species production and TRPA1 sensitization
Paclitaxel Drug-Coated Balloons A Review of Current Status and Emerging Applications in Native Coronary Artery De Novo Lesions
Paclitaxel and Bevacizumab as First Line Combined Treatment in Patients with Metastatic Breast Cancer: The Hellenic Cooperative Oncology Group Experience with Biological Marker Evaluation
Paclitaxel and bevacizumab in first-line treatment for HER2-negative metastatic breast cancer: single-center experience
Paclitaxel and bevacizumab with or without capecitabine as first-line treatment for HER2-negative locally recurrent or metastatic breast cancer: A multicentre, open-label, randomised phase 2 trial
Paclitaxel-Eluting Biodegradable Synthetic Vascular Prostheses A Step Towards Reduction of Neointima Formation?
Paclitaxel-Eluting Stents Compared With Bare Metal Stents in Diabetic Patients With Acute Myocardial Infarction The Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction (HORIZONS-AMI) Trial
Paclitaxel induced apoptosis in breast cancer cells requires cell cycle transit but not Cdc2 activity
Paclitaxel, a double-edged sword for tumor and platelets
Paclitaxel-induced neuropathy: potential association of MAPT and GSK3B genotypes
Paclitaxel-loaded poly(lactic-co-glycolic acid) microspheres: preparation and in vitro evaluation
Paclitaxel loaded nano-aggregates based on pH sensitive polyaspartamide amphiphilic graft copolymers
Paclitaxel-conjugated PEG and arginine-grafted bioreducible poly (disulfide amine) micelles for co-delivery of drug and gene
Paclitaxel-loaded ethosomes (R): Potential treatment of squamous cell carcinoma, a malignant transformation of actinic keratoses
Paclitaxel-Eluting Stents versus Bare-Metal Stents in Acute Myocardial Infarction.
Paclitaxel induces vascular endothelial growth factor expression through reactive oxygen species production
Paclitaxel-resistance Conferred by Altered Expression of Efflux and Influx Transporters for Paclitaxel in the Human Hepatoma Cell Line, HepG2
Paclitaxel promotes a caspase 8-mediated apoptosis through death effector domain association with microtubules
Paclitaxel alters the expression and specific activity of deoxycytidine kinase and cytidine deaminase in non-small cell lung cancer cell lines
Paclitaxel production is enhanced in suspension-cultured hazel (Corylus avellana L.) cells by using a combination of sugar, precursor, and elicitor
Paclitaxel augments cytotoxic effect of photodynamic therapy using verteporfin in gastric and bile duct cancer cells
Paclitaxel (Taxol): From nutt to drug
Paclitaxel, 5-fluorouracil and hydroxyurea concurrent with radiation in locally advanced nasopharyngeal carcinoma
Paclitaxel uptake and transport in Taxus cell suspension cultures
Paclitaxel combined with oxaliplatin as first-line chemotherapy for locally advanced or metastatic gastric cancer
Paclitaxel treatment of breast cancer cell lines modulates Fas/Fas ligand expression and induces apoptosis which can be inhibited through the CD40 receptor
Paclitaxel encapsulated in cationic lipid complexes (MBT-0206) impairs functional tumor vascular properties as detected by dynamic contrast enhanced magnetic resonance Imaging
Paclitaxel, ifosfamide, and nedaplatin as second-line treatment for patients with metastatic urothelial carcinoma: A phase II study of the SUOC group
Paclitaxel coated balloons for coronary artery interventions: A comprehensive review of preclinical and clinical data
Paclitaxel in combination with sorafenib and bevacizumab in patients with locally advanced or metastatic solid tumors
Paclitaxel Increases High Voltage-Dependent Calcium Channel Current in Dorsal Root Ganglion Neurons of the Rat
Paclitaxel chemotherapy for the treatment of gastric cancer
Paclitaxel-Eluting Stents Show Superiority to Balloon Angioplasty and Bare Metal Stents in Femoropopliteal Disease Twelve-Month Zilver PTX Randomized Study Results
Paclitaxel and Trastuzumab as Maintenance Therapy in Patients with HER2-Positive Metastatic Breast Cancer Who Underwent High-Dose Chemotherapy and Autologous Hematopoietic Stem Cell Transplantation
Paclitaxel binding to human and murine MD-2
Paclitaxel Resistance by Random Mutagenesis of alpha-Tubulin
Paclitaxel-Coated Balloon Angioplasty vs. Plain Balloon Dilation for the Treatment of Failing Dialysis Access: 6-Month Interim Results From a Prospective Randomized Controlled Trial
Paclitaxel release from single and double-layered poly(DL-lactide-co-glycolide)/poly(L-lactide) film for biodegradable coronary stent application
Paclitaxel Potentiates Inflammatory Cytokine-induced Prothrombotic Molecules in Endothelial Cells
Paclitaxel Nanocrystals for Overcoming Multidrug Resistance in Cancer
Paclitaxel in the neoadjuvant treatment for adeno carcinoma of the distal esophagus (AEG I). A comparison of two phase II trials with long-term follow-up
Paclitaxel-Eluting Polymer Film Reduces Locoregional Recurrence and Improves Survival in a Recurrent Sarcoma Model: A Novel Investigational Therapy
Paclitaxel efficacy and toxicity in older women with metastatic breast cancer: combined analysis of CALGB 9342 and 9840
Paclitaxel promotes differentiation of myeloid-derived suppressor cells into dendritic cells in vitro in a TLR4-independent manner
Paclitaxel-Induced Endothelial Dysfunction in Living Rats Is Prevented by Nicorandil via Reduction of Oxidative Stress
Paclitaxel and cisplatin chemotherapy for metastatic urothelial carcinoma after failure of two courses of platinum-based regimens
Paclitaxel/Epigallocatechin gallate coloaded liposome: A synergistic delivery to control the invasiveness of MDA-MB-231 breast cancer cells
Paclitaxel-eluting balloon angioplasty and cobalt-chromium stents versus conventional angioplasty and paclitaxel-eluting stents in the treatment of native coronary artery stenoses in patients with diabetes mellitus
Paclitaxel-induced hyperalgesia modulates negative affective component of pain and NR1 receptor expression in the frontal cortex in rats
Paclitaxel-eluting balloon dilation of biliary anastomotic stricture after liver transplantation
Paclitaxel-loaded poly(lactide-co-glycolide)/poly(ethylene vinyl acetate) composite for stent coating by ultrasonic atomizing spray
Paclitaxel as an anticancer agent: isolation, activity, synthesis and stability
Paclitaxel/carboplatin with or without sorafenib in the first-line treatment of patients with stage III/IV epithelial ovarian cancer: a randomized phase II study of the Sarah Cannon Research Institute
Paclitaxel-loaded poly(gamma-glutamic acid)-poly(lactide) nanoparticles as a targeted drug delivery system for the treatment of liver cancer
Paclitaxel-loaded poly(gamma-glutamic acid)-poly(lactide) nanoparticles as a targeted drug delivery system against cultured HepG2 cells
Paclobutrazol enhances photosynthesis and ajmalicine production in Catharanthus roseus
Paclitaxel-loaded hollow-poly(4-vinylpyridine) nanoparticles enhance drug chemotherapeutic efficacy in lung and breast cancer cell lines
Paclitaxel-Coated Balloons for the Treatment of Dysfunctional Dialysis Access. Results from a Single-Center, Retrospective Analysis